Article ; Online: Protein and Antibody Engineering: Suppressing Degranulation of the Mast Cells and Type I Hypersensitivity Reaction.
Current protein & peptide science
2020 Volume 21, Issue 8, Page(s) 831–841
Abstract: With an increase in atopic cases and owing to a significant role of mast cells in type I hypersensitivity, a therapeutic need to inhibit degranulation of mast cells has risen. Mast cells are notorious for IgE-mediated allergic response. Advancements have ...
Abstract | With an increase in atopic cases and owing to a significant role of mast cells in type I hypersensitivity, a therapeutic need to inhibit degranulation of mast cells has risen. Mast cells are notorious for IgE-mediated allergic response. Advancements have allowed researchers to improve clinical outcomes of already available therapies. Engineered peptides and antibodies can be easily manipulated to attain desired characteristics as per the biological environment. A number of these molecules are designed to target mast cells in order to regulate the release of histamine and other mediators, thereby controlling type I hypersensitivity response. The aim of this review paper is to highlight some of the significant molecules designed for the purpose. |
---|---|
MeSH term(s) | Adrenal Cortex Hormones/therapeutic use ; Animals ; Antibodies, Monoclonal/therapeutic use ; Cell Degranulation/drug effects ; Cell Degranulation/immunology ; Desensitization, Immunologic/methods ; Gene Expression ; Histamine/biosynthesis ; Histamine/immunology ; Histamine Antagonists/therapeutic use ; Humans ; Hypersensitivity, Immediate/genetics ; Hypersensitivity, Immediate/immunology ; Hypersensitivity, Immediate/pathology ; Hypersensitivity, Immediate/therapy ; Immunoglobulin E/biosynthesis ; Immunosuppressive Agents/therapeutic use ; Mast Cells/drug effects ; Mast Cells/immunology ; Mast Cells/pathology ; Protein Engineering/methods ; Protein Kinase Inhibitors/therapeutic use ; Receptors, Fc/genetics ; Receptors, Fc/immunology |
Chemical Substances | Adrenal Cortex Hormones ; Antibodies, Monoclonal ; Histamine Antagonists ; Immunosuppressive Agents ; Protein Kinase Inhibitors ; Receptors, Fc ; Immunoglobulin E (37341-29-0) ; Histamine (820484N8I3) |
Language | English |
Publishing date | 2020-04-23 |
Publishing country | United Arab Emirates |
Document type | Journal Article ; Review |
ZDB-ID | 2045662-1 |
ISSN | 1875-5550 ; 1389-2037 |
ISSN (online) | 1875-5550 |
ISSN | 1389-2037 |
DOI | 10.2174/1389203721666200511094717 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 5884: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.